ARTICLE | Clinical News
PT003: Phase IIb data
January 16, 2012 8:00 AM UTC
Top-line data from a double-blind, international Phase IIb trial in 237 patients showed that twice-daily PT003, PT001 and PT005 administered via a metered dose inhaler met the primary endpoint of no s...